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that both eGFR creat and eGFR cystC are influenced by BMI 
and BSA. eGFR creat is more strongly influenced by body 
 composition than eGFR cystC .  © 2017 S. Karger AG, Basel 
 Introduction 
 Glomerular filtration rate (GFR) plays a key role in the 
management of kidney disease. Ideally, measuring GFR 
should be based on renal clearances of exogenous mark-
ers such as inulin, but this approach is complex, invasive, 
and expensive  [1] . Therefore, GFR is commonly estimat-
ed based on creatinine blood concentrations  [2] . Using 
creatinine as marker of renal function has some limita-
tions. Creatinine is actively secreted by the proximal tu-
bule and related to muscle mass, age, sex, ethnicity, and 
dietary factors  [1, 3] . Creatinine concentrations can be 
higher in individuals with an increased muscle mass, in-
dependent of kidney function, leading to an underestima-
tion of eGFR  [4] . Studies in adults suggest that eGFR 
based on creatinine concentrations can be improved if 
lean mass percentage could be incorporated in the for-
mula  [4] .
 An alternative marker for the estimation of GFR is cys-
tatin C, the concentrations of which are reported to be 
independent of muscle mass in children  [5, 6] . Some au-
thors report a superior sensitivity of cystatin C for detect-
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 Abstract 
 Background: Creatinine and cystatin C concentrations are 
commonly used to estimate glomerular filtration rate (eGFR) 
in clinical practice and epidemiological studies. To estimate 
the influence of different body composition measures on 
eGFR from creatinine and cystatin C blood concentrations, 
we compared the associations of different anthropometric 
and body composition measures with eGFR derived from 
creatinine (eGFR creat ) and cystatin C (eGFR cystC ) blood con-
centrations.  Methods: In a population-based cohort study 
among 4,305 children aged 6.0 years (95% range 5.7–8.0), we 
measured weight and height and calculated body mass in-
dex (BMI) and body surface area (BSA), and lean and fat mass 
using dual-energy X-ray absorptiometry. At the same age, 
we measured creatinine and cystatin C blood concentrations 
and estimated the GFR.  Results: Correlation between eGFR 
based on creatinine and cystatin C concentrations was  r = 
0.40 ( p value <0.01). Higher BMI was associated with lower 
eGFR cystC but not with eGFR creat . Higher BSA was associated 
with higher eGFR creat and lower eGFR cystC ( p value <0.05). 
Lean and fat mass percentages were associated with  eGFR creat 
but not with eGFR cystC .  Conclusion: Our findings suggest 
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ing impaired GFR in pediatric patients to that of creati-
nine, especially in children with low muscle mass  [7] . 
However, studies in kidney disease patients suggest that 
lean mass affects cystatin C concentrations  [8, 9] . Many 
studies have explored the associations between body mass 
index (BMI) and eGFR, using BMI as a proxy for body 
composition  [10, 11] . To our knowledge, large popula-
tion-based studies in healthy children comparing the cor-
relations and associations of detailed body composition 
measures, next to BMI, with the estimates of GFR are 
lacking.
 To estimate the influence of different body composi-
tion measures on eGFR from creatinine and cystatin C 
blood concentrations, we compared the associations of 
different anthropometric and body composition mea-
sures with eGFR derived from creatinine (eGFR creat ) and 
cystatin C (eGFR cystC ) blood concentrations in a popula-
tion-based prospective cohort study among 4,305 chil-
dren who were 6 years of age.
 Methods 
 Design and Study Population 
 This study was embedded in the Generation R Study, a popu-
lation-based prospective cohort study from fetal life onward in 
Rotterdam, The Netherlands, which has been described in detail 
previously  [12] . The study has been approved by Medical Ethical 
Committee of Erasmus MC, University Medical Center  Rotterdam. 
All children were born between April 2002 and January 2006 and 
form a largely prenatally enrolled birth cohort that is currently be-
ing followed until young adulthood. Written consent was obtained 
for all children. The present analyses were performed among 4,305 
children whose body composition details and kidney function 
measures available (online suppl. Fig. 1; for all online  suppl. mate-
rial, see www.karger.com/doi/10.1159/000463395).
 Body Composition Measurements 
 Children’s anthropometrics and body composition were mea-
sured at a median age of 6.0 years (95% range 5.7–8.0)  [12] . Height 
(m) was determined in standing position to the nearest millimeter 
without shoes using a Harpenden stadiometer (Holtain Limited, 
Dyfed, UK). Weight was measured using a mechanical person-
al  scale (SECA, Almere, The Netherlands). We calculated BMI 
(kg/m 2 ) and body surface area (BSA; m 2 ). For BSA, we used the 
DuBois formula: BSA = weight (kg) 0.425 × height (cm) 0.725 × 
0.007184. Whole body dual-energy X-ray absorptiometry (DXA) 
scans (iDXA, GE-Lunar, 2008, Madison, WI, USA) were per-
formed to estimate fat and lean mass. We calculated lean mass 
percentage as (lean mass [kg]/weight [kg]) and fat mass percent-
age as (fat mass [kg]/weight [kg]).
 Kidney Function Measurements 
 Non-fasting blood samples were drawn by antecubital veni-
puncture and centrifuged for 10 min and stored at –80   °   C at one 
location in the Stichting Trombosedienst and Artsenlaboratorium 
Rijnmond (STAR)-MDC laboratory. As previously described, cre-
atinine concentrations were measured with enzymatic methods 
and cystatin C concentrations with a particle enhanced immuno-
turbidimetric assay (using Cobas 8000 analyzers, Roche, Almere, 
The Netherlands). Quality control samples demonstrated intra- 
and inter-assay coefficients of variation of 0.51% for creatinine and 
1.65% for cystatin C, and 1.37% for creatinine and 1.13% for cys-
tatin C, respectively  [13] . We calculated the eGFR based on cre-
atinine concentrations according to the revised Schwartz 2009 for-
mula: eGFR creat = 36.5  * (height [cm]/serum creatinine [μmol/L]) 
 [14] , and eGFR based on cystatin C concentrations using 
 Zappitelli’s formula: eGFR cystC = 75.94/(CysC [mg/L] 1.17 )  [15] .
 Statistical Analysis 
 We performed a non-response analysis by comparing subject 
characteristics between children with and without kidney function 
measurements using  t tests, chi-square tests, and Mann–Whitney 
tests. We created SDs scores for all body composition measures to 
enable comparison between effect estimates. Next, we examined 
the Pearson rank correlation coefficients between childhood an-
thropometrics, body composition, and eGFR measures. Third, we 
used multiple linear regression analyses to examine the associa-
tions of anthropometric and body composition measures with cre-
atinine, cystatin C, eGFR creat , and eGFR cystC . The linear regression 
models were adjusted for child sex, age at measurements, and eth-
nicity. Additionally, we explored the associations of childhood 
BMI clinical cutoffs with creatinine, cystatin C, and eGFRs.  Because 
of the already reported associations of ethnicity with kidney func-
tion markers, we performed a sensitivity analysis in children of 
European ethnicity, the largest ethnic subgroup  [16] . Based on pre-
vious literature, we assessed whether the explored association dif-
fered by sex, which was not the case in this study  [17, 18] . All anal-
yses were performed using the Statistical Package for the Social 
Sciences version 21.0 for Windows (SPSS IBM, Chicago, IL, USA).
 Results 
 Participant Characteristics 
 Online supplementary Figure 1 describes the selection 
of the study population. At the median age of 6 years (95% 
range 5.7–8.0) a total of 8,305 children participated in the 
study follow-up measurements. Of these children, 6,509 
(78%) visited the research center for body composition 
measurements. In this study, we excluded children with 
congenital kidney abnormalities ( n  = 12). A total of 6,497 
children were available for kidney function measure-
ments. Of these children, 2,192 children did not have kid-
ney measurements. The present analyses were performed 
among 4,305 children whose body composition and kid-
ney function measures available.
 Table 1 shows the characteristics of the participants. In 
the full group, the mean (SD) eGFR creat and eGFR cystC were 
118.9 mL/min/1.73 m 2 (15.9) and 101.6 mL/min/1.73 m 2 
(11.2), respectively. The histograms of  creatinine, cystatin 
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C, eGFR creat , and eGFR cystC are provided in online supple-
mentary Figure 2. Results from the non-response analyses 
are given in the online supplementary Table 1. Children 
with kidney function measurements had higher lean mass 
percentage and lower fat mass percentage compared to 
children who did not have kidney function measurements.
 Correlations of Childhood Anthropometrics and Body 
Composition Measures with eGFR 
 The Pearson rank correlation coefficient between 
 eGFR creat and eGFR cystC was  r = 0.40 ( p value <0.01; 
 Table 2 ). Childhood height, weight, BMI, and BSA were 
positively correlated with creatinine and cystatin C con-
centrations, with stronger coefficients for creatinine con-
centrations ( p value <0.01). Lean mass percentage was 
positively correlated with creatinine concentrations and 
negatively correlated with eGFR creat ( r = 0.13,  p value 
<0.01). Similar results, but in opposite directions, were 
observed for fat mass percentage. Lean mass percentage 
and fat mass percentage were not correlated with cystatin 
C concentrations or eGFR cystC .
 Associations of Childhood Body Composition 
Measures with eGFR 
 Table  3 shows the results from the linear regression 
models. Childhood height was associated with creatinine 
concentrations ( p value <0.05), but not with cystatin C 
concentrations. Higher childhood weight was associated 
with both higher creatinine and cystatin C concentrations 
( p value <0.01). Higher childhood height was associated 
with higher eGFR creat ( p value <0.01), but not with  eGFR cystC 
whereas higher childhood weight was associated with 
higher eGFR creat and lower eGFR cystC ( p value <0.01).
 Each 1-SD increase in BSA was associated with 1.81 
mL/min/1.73 m 2 (95% CI 1.24–2.37) higher eGFR creat and 
0.57 mL/min/1.73 m 2 (95% CI –0.98 to –0.17) lower 
 eGFR cystC . BMI was negatively associated with eGFR cystC 
( p  value <0.05) but not with eGFR creat . We observed ten-
dencies for similar effect estimates when we restricted the 
analyses to Europeans only ( n = 2,727; online suppl. 
 Table  2). The associations of BMI clinical cutoffs with 
creatinine, cystatin C, and the eGFR are given in online 
supplementary Table 3.
 Higher lean mass percentage was associated with higher 
creatinine concentrations and with lower cystatin C con-
centrations ( Table 3 ;  p value <0.05). A 1-SD increase in lean 
mass percentage was associated with 2.74 mL/min/1.73 m 2 
(95% CI –3.27 to –2.20) lower childhood eGFR creat . No as-
sociation was observed of lean mass percentage with 
 eGFR cystC .
 Similar results, but in an opposite direction, were ob-
served for fat mass percentage ( Table  3 ). We observed 
similar effect estimates when we restricted our analyses to 
European subjects only, although not all associations 
were significant (online suppl. Table 2).
 Discussion 
 Results of this cross-sectional study in healthy 6-year-
old children suggest that BMI and BSA are associated 
with creatinine-based and cystatin C-based eGFRs. Lean 
mass percentage and fat mass percentage are associated 
with creatinine-based eGFR, but not with cystatin  C-based 
eGFR.
 Interpretation of Main Findings 
 To our knowledge, this is the first large population-
based study in healthy school-age children comparing the 
association of detailed measures of body composition us-
ing DXA scans with estimates of GFR based on creatinine 
and cystatin C concentrations. Both creatinine and cys-
tatin C concentrations can be influenced by different fac-
tors. Creatinine is produced in active muscle and is re-
Table 1.  Subjects characteristics (n = 4,305)
Age at measurements, years 6.0 (5.7–8.0)
Gender, female, % 48.3
Ethnicity, %
Dutch or European 65.1
Non-European 34.9
Height, m 119.7 (6.0)
SD score*, mean (SD) –0.2 (1.0)
Weight, kg 23.4 (4.2)
SD score*, mean (SD) 0.1 (1.0)
Body mass index, kg/m2 16.2 (1.8)
SD score*, mean (SD) 0.3 (0.9)
Body surface area, m2 0.88 (0.09)
Fat mass percentage, % 24.7 (5.6)
Lean mass percentage, % 71.7 (5.4)
eGFRcreat, mL/min/1.73 m2 118.9 (15.9)
eGFRcystC, mL/min/1.73 m2 101.6 (11.2)
 Values are percentages for categorical variables, means (SD) for con-
tinuous variables with a normal distribution, or medians (95% range) for 
continuous variables with a skewed distribution. * The SD scores were 
obtained using Dutch reference growth curves (Growth Analyzer 3.0, 
Dutch Growth Research Foundation, Rotterdam, The Netherlands). 
 eGFRcreat, estimated glomerular filtration rate calculated based on crea-
tinine blood concentrations; eGFRcreat = 36.5 * (height [cm]/serum cre-
atinine [μmol/L]); eGFRcystC, estimated glomerular filtration rate calcu-
lated based on cystatin C blood concentrations; eGFRcystC = 75.94/(cysC 
[mg/L]1.17).
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ported to be determined by muscle mass and dietary in-
take, which may account for the variations in the 
concentrations of serum creatinine observed among dif-
ferent age and ethnic groups  [1, 3] . However, we have 
previously reported that childhood protein intake does 
not influence the eGFR  [19] . Cystatin C is another mark-
er to evaluate renal function, although it is not used as 
commonly as creatinine  [6, 20] . Cystatin C is produced 
by all nucleated cells and reported to be less strongly re-
lated to body weight and height in children compared to 
creatinine  [5, 7] . Besides, adult studies suggest that cys-
tatin C concentrations are related to age, sex, height, and 
weight and influenced by corticosteroid use  [17, 21] .
 In children, the Schwartz formula is widely used to es-
timate GFR from creatinine concentrations  [14] . The 
Schwartz formula is known to overestimate eGFR com-
pared to inulin clearance GFR  [6, 22, 23] . Schwartz for-
mula estimates GFR using creatinine concentrations and 
child height  [14] . Therefore, the observed effect estimates 
in the current study of height on eGFR creat might clini-
cally not be relevant. Next to Schwartz’s formula, we es-
timated GFR using the Zappitelli’s formula  [15] . This for-
mula is not dependent of any anthropometric measures. 
It estimates GFR by using only the cystatin C concentra-
tions  [15] . In a study among 42 healthy adults, eGFR us-
ing creatinine and cystatin C concentrations were com-
pared with measured GFR. This study suggested that 
eGFR based on cystatin C concentrations was a better 
marker then eGFR based on creatinine concentrations for 
estimating kidney function  [24] .
Table 3.  Associations of anthropometric and body composition measures with creatinine, cystatin C, and eGFR (n = 4,305)
Anthropometrics and 
body composition (SDS)
 Difference (95% CI)
 creatinine, 
μmol/L
cystatin C, 
μg/L
eGFRcreat, 
mL/min/1.73 m2
eGFRcystC, 
mL/min/1.73 m2
Height 0.97 (0.79 to 1.15)*** 1.99 (–0.70 to 4.70) 2.78 (2.22 to 3.35)*** –0.29 (–0.70 to 0.12)
Weight 0.91 (0.73 to 1.08)*** 4.49 (1.91 to 7.07)*** 1.16 (0.61 to 1.71)*** –0.66 (–1.05 to –0.27)**
Body mass index 0.52 (0.36 to 0.68)*** 4.15 (1.80 to 6.51)*** –0.37 (–0.87 to 0.13) –0.61 (–0.96 to –0.26)**
Body surface area 1.02 (0.84 to 1.20)*** 3.93 (1.27 to 6.59)** 1.81 (1.24 to 2.37)*** –0.57 (–0.98 to –0.17)**
Lean mass percentage 0.30 (0.07 to 0.54)* –2.73 (–5.28 to –0.18)* –2.74 (–3.27 to –2.20)*** 0.36 (–0.03 to 0.74)
Fat mass percentage –0.48 (–0.65 to –0.31)*** 2.86 (0.32 to 5.40)* 2.68 (2.14 to 3.21)*** –0.38 (–0.76 to 0.01)
 Values are beta coefficients and 95% CIs, from linear regression models adjusted for child age, sex, and ethnicity. eGFRcreat, estimated 
glomerular filtration rate calculated based on creatinine blood concentrations; eGFRcystC, estimated glomerular filtration rate calculated 
based on cystatin C blood concentrations.
p value for the associations * p < 0.05, ** p < 0.01, and *** p < 0.001.
Table 2.  Correlation coefficients of the investigated variables
Height Weight BMI BSA FMP LMP Creat Cyst C eGFRcreat eGFRcystC
Height 1.00
Weight 0.77* 1.00
BMI 0.31* 0.83* 1.00
BSA 0.90* 0.97* 0.69* 1.00
FMP 0.18* 0.57* 0.69* 0.46* 1.00
LMP –0.19* –0.56* –0.68* –0.45* –0.999* 1.00
Creat 0.30* 0.28* 0.16* 0.30* –0.05* 0.05* 1.00
Cyst C 0.05* 0.06* 0.05* 0.06* –0.001 0.003 0.40* 1.00
eGFRcreat 0.06* 0.01 –0.04* 0.03 0.12* –0.13* –0.92* –0.40* 1.00
eGFRcystC –0.05* –0.06* –0.05* –0.06* 0.01 –0.01 –0.39* –0.99* 0.40* 1.00
 * Correlation is significant at the 0.01 level (2-tailed).
BMI, body mass index; BSA, body surface area; FMP, fat mass percentage; LMP, lean mass percentage; creat, creatinine; Cyst C, 
cystatin C; eGFRcreat, estimated glomerular filtration calculated based on creatinine blood concentrations; eGFRcystC, estimated glomerular fil-
tration calculated based on cystatin C blood concentrations.
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 It has previously been reported that lean body mass, 
indicating muscular mass, is an important determinant 
of the GFR  [25] . So far, results from studies comparing 
the effects of body composition measures on creatinine 
and cystatin C concentrations and their derived eGFR 
are contradictory  [8, 26] . A number of studies have ex-
plored the associations of BMI with eGFR, using BMI as 
a proxy of body composition  [10, 11] . The associations 
of BMI with creatinine and cystatin C differed between 
populations studied. We observed that higher BMI 
was  associated with higher creatinine and cystatin C 
 concentrations and with lower eGFR cystC , but not with 
 eGFR creat . In the subgroup of Europeans, we observed 
that BMI was associated with creatinine, cystatin C con-
centrations, and their derived eGFRs. In line with 
our  findings in the European subgroup, in the general 
Japanese population, BMI was associated with lower 
 eGFR creat  [11] . Similar to what we observe, studies among 
both healthy and kidney disease adults suggested that 
eGFR based on cystatin C concentrations is not indepen-
dent of BMI  [8, 27] . These findings appear to be different 
among children with various kidney diseases, where BMI 
does not have a clinically relevant effect on eGFR cystC 
 [10] . Next to BMI, we observed that higher BSA was as-
sociated with higher creatinine, cystatin C concentra-
tions, eGFR creat , and lower eGFR cystC . The effect esti-
mates for the associations of BMI and BSA with eGFRs 
are relatively small. Studying detailed measures of body 
composition will therefore likely add to the understand-
ing of the associations of body composition and kidney 
function measures.
 Studies among healthy adults have shown lean mass 
percentage to be associated with serum creatinine and 
eGFR based on creatinine concentrations but not with 
cystatin C concentrations  [4, 26] . A study among 67 
healthy individuals of ages between 18 and 52 years has 
shown that creatinine concentrations were highly affect-
ed by muscle mass, whereas cystatin C concentrations 
were affected by fat mass  [28] . The associations between 
lean mass and cystatin C are reported to be different 
among kidney disease patients  [8] . Among 77 chronic 
kidney disease patients lean mass affected cystatin C con-
centrations, and GFR estimation based on cystatin C con-
centrations improved when lean mass was included in the 
formula, especially in patients with extreme body compo-
sition  [8] . In severely obese children, lean mass percent-
age has been reported to correlate with both creatinine 
and cystatin C concentrations  [29] . In the current study, 
we observed that lean and fat mass percentage correlate 
with creatinine concentrations and eGFR creat . Higher lean 
mass percentage and lower fat mass percentage were as-
sociated with higher creatinine concentrations and lower 
eGFR creat . We did not observe a significant correlation of 
lean mass percentage or fat mass percentage with cystatin 
C concentrations. Our study shows that eGFR based on 
cystatin C concentrations is independent of lean mass 
percentage and fat mass percentage.
 Our findings suggest that eGFR creat is more strongly 
influenced by body composition than eGFR cystC .  How-
ever, their impact on clinical care may be limited. As 
the revised Schwartz formula (eGFR creat ) is the most 
widely used formula both in epidemiological studies 
and clinical practice, our findings suggest that body 
composition measures should be considered when 
eGFR is based on creatinine concentrations. Ideally, 
body composition measures would have been incorpo-
rated in the eGFR creat equations and compared with 
GFR based on renal clearances of exogenous markers, 
but unfortunately this is not possible in our study. 
 Considering the feasibility and costs of performing 
DXA scans in school-age children, whether and to what 
 extent detailed body composition measures should 
be  used in the clinical practice when estimating GFR 
can be argued. Other studies are needed to assess 
whether using eGFR cystC instead of eGFR creat leads to 
better care for pediatric kidney patients.
 Strengths and Limitations 
 To the best of our knowledge, this is the first and larg-
est cross-sectional multiethnic study in a healthy pediat-
ric population-based cohort examining the associations 
of body composition with estimates of GFR. GFR was es-
timated based on creatinine and cystatin C concentra-
tions. Except height and weight to calculate BMI and 
BSA, we also measured fat mass and lean mass with DXA. 
Of all children, 61% provided blood samples for measur-
ing creatinine and cystatin C concentrations. Children 
without data on kidney function measures were shorter, 
had a higher fat mass percentage, and lower lean mass 
percentage. The difference in fat and lean mass percent-
age may be explained by the higher percentage of girls in 
the group without available kidney measures. There was 
no difference in BMI between the children with and with-
out available kidney function measures. We observed 
tendencies for similar effect estimates among Europeans 
only, although not all associations were significant in this 
subgroup. This might be due to the smaller study group, 
but may also reflect an effect of ethnicity. Ideally, we 
would have been able to compare the explored associa-
tions with the measured GFR and validate our findings. 
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Unfortunately, we do not have the urinary or plasma 
clearance of an ideal filtration marker, such as inulin, 
 iothalamate, or iohexol, as the gold standard for the mea-
surement of GFR  [30] . Our findings are based on a healthy 
pediatric population of a narrow age category and may 
not be generalizable to older, younger, or diseased popu-
lations.
 Conclusion 
 Our results suggest that eGFR based on both creati-
nine and cystatin C concentrations are influenced by 
BMI and BSA, whereas only eGFR based on creatinine 
concentrations is influenced by lean mass percentage 
and fat mass percentage. Beside anthropometric mea-
surements, body composition measures should be con-
sidered when estimating GFR in children. Further stud-
ies to compare these results with measured GFR are 
needed.
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